RPE (usual care)
BehavioralPatients in the active comparator group will follow standard exercise prescription protocols in cardiac rehabilitation.
Other names: Relative Perceived Exertion (RPE) Exercise Group
NCT Number: NCT05925634
The goal of this clinical trial is to compare two types of exercise prescriptions in cardiac rehabilitation eligible older adults (60 years or older) with heart disease. The investigators found in a single site pilot trial (insert NCTxxx) that one exercise prescription was better and are now repeating this study in a larger population at two sites (Baystate Medical Center, Springfield MA and Henry Ford Health System, Detroit MI). The main questions the investigators aim to answer are:
1. Compare two different exercise prescriptions in cardiac rehabilitation on exercise outcomes
1. Graded exercise test +Target heart rate range prescription [GXT-THRR] 2. Rating of perceived exertion (RPE) 2. What is the role of psychological feedback on fitness outcomes during cardiac rehabilitation and physical activity outside of cardiac rehabilitation. 3. What are the long-term clinical outcomes between the two exercise prescriptions
Participants will be asked to:
* Complete surveys about physical activity, exercise anxiety, exercise efficacy, and fears about exercising * Perform fitness measures (6-minute walk test, balance tests, stand to sit tests, a 400 meter walk, and handgrip strength) * Attend at least 18 sessions of cardiac rehabilitation after they are randomized to their exercise prescription group * Wear a heart rate monitor and a physical activity monitor per study protocol
Participants will be randomized (flip of a coin) to either receive a graded exercise test and psychoeducational feedback or lifestyle education (nutrition for cardiac). The graded exercise test will be used to create a personalized exercise prescription with the target heart rate range calculated from the test and the lifestyle education group will use their ratings of perceived exertion for their exercise prescription.
Interested in participating?
Request Info60 year–99 year
All sexes
Interventional
Phase 2
Baystate Medical Center, Springfield, Massachusetts, United States
This study aims to conduct a practical two-arm, parallel-group, open-label, efficacy randomized trial comparing Graded Exercise Testing+ Target Heart Rate Range (GXT-THRR) vs. Usual Care (UC) on changes in fitness (as measured by 6MWT, exercise training METs, handgrip strength and Short Physical Performance Battery [SPPB]) and PA behavior among 320 patients enrolled in CR. The investigators will recruit older adults (age ≥ 60 years) attending outpatient CR from two complementary but different CR centers. The investigators will compare changes in fear and self-efficacy between these two groups and measure long-term clinical outcomes. The investigators have designed the study to be as generalizable as possible, so most CR programs can immediately apply the results in clinical practice.
Eligible patients who are willing to participate will complete written informed consent. Baseline demographics, comorbidities, and prescribed medications and doses (including beta-blockers) will be collected.
Patients will then undergo a baseline assessment. This will include a 6MWT and SPPB using standard guideline procedures. During this time period, patients will also be fitted with an accelerometer to wear for 7 days (Actigraph, CenterPoint, Pensacola, FL) to assess time spent in moderate to vigorous PA (MVPA). The investigators have significant experience assessing PA, 6MWT, and SPPB, and anticipate few issues in making these measurements. Patients will also complete the following psychological assessments:
During the time between informed consent and randomization, patients will continue to undergo CR using UC to guide intensity. This allows for exercise-related baseline measurements to be taken, including the exercise training METs on the 3rd session of CR, as suggested by AACVPR performance measures. It also allows measurement of baseline resting HR, exercise HR, and exercise RPE.
After completing all baseline assessments (including 3 sessions of CR), patients will be randomized (1:1) to either GXT-THRR or UC. Randomization will be stratified based on age, recent cardiac surgery, and site (Baystate vs. Henry Ford.) This will be done because age may have a differential impact on exercise gains; cardiac surgery can limit the available exercise training modalities (i.e., no upper body exercises); and CR site may influence the outcome in unanticipated ways. The investigators will randomize patients through use of the Research Electronic Database Capture (REDCap) software randomization module which allows secure, sequential, and concealed group allocation, as was done in the pilot. REDCap will also be used by both sites to allow uniform data collection, capture, and entry.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
These include conditions that alter the physiology and monitoring of resting and exercise heart rate. These also include conditions that might limit an individual's ability to exercise.
Patients in the active comparator group will follow standard exercise prescription protocols in cardiac rehabilitation.
Other names: Relative Perceived Exertion (RPE) Exercise Group
Patients in the personalized care group will perform a graded exercise test and the peak heart rate from the test will allow the researcher to calculate a target heart rate range (THRR). Then, the patients will receive psychoeducational feedback (PF) about their test results and exercise performance. After PF, their THRR will be reviewed and how it will be used to guide exercise intensity in CR will be discussed.
Other names: Experimental: Graded Exercise Test (GXT) + Target Heart Rate Range (THHR)
Time frame: Baseline to final CR session
Change in functional fitness as measured by 6 minute walk from baseline to cardiac rehabilitation (CR) completion.
Time frame: 3rd CR session to final CR session
Change in metabolic equivalents of task (METs)-an objective measure of a training exercise workload as changes in scores over time and between groups.
Time frame: Baseline to final CR session
Change in Short Physical Performance Battery from baseline to final CR session
Time frame: From end of final CR session to 6 months later.
Change in functional fitness as measured by 6-minute walk from end of CR to 6 months later.
Time frame: From end of final CR session to 6 months later.
Short Physical Performance Battery from end of CR to 6 months later.
Time frame: Pre-Post GXT
Acute change in self-efficacy (task efficacy) measured before and after the intervention (graded exercise test (GXT) vs. time matched control) will be assessed via the Multidimensional Self-Efficacy for Exercise Scale as changes in scores over time and between groups.
Time frame: Pre-Post GXT
Acute effects of GXT vs. time matched control on fear will be measured via the Exercise Sensitivity Questionnaire as changes in scores over time and between groups.
Time frame: Pre-Post GXT
Acute effects of GXT on reassurance will be measured via the Reassurance Scale as change scores over time and between groups.
Time frame: Baseline to final CR session
Change in exercise anxiety from baseline to final CR session over time and between groups will be measured via the Exercise Sensitivity Questionnaire.
Time frame: Baseline to final CR session
Change in exercise self-efficacy from baseline to final CR session over time and between groups will be measured via the Preference for and Tolerance of Exercise Intensity Questionnaire.
Time frame: Baseline to final CR session
Change in task self-efficacy from baseline to final CR session over time and between groups will be measured via the Multidimensional Self-Efficacy for Exercise Scale.
Time frame: Baseline to final CR session
Change in Quality of Life measured by the SF-36 from baseline to the end of CR
Time frame: Baseline to final CR session
Total minutes/day in moderate to vigorous physical activity that is structured exercise behavior measured with an accelerometer.
Time frame: Baseline to CR end, and at 3 and 6 months post CR
Using the International physical activity questionnaire (IPAQ) to measure self-reported moderate to vigorous physical activity (MVPA) over the past 7 days
Time frame: At end of CR up to 2 years follow-up
A cardiovascular event including myocardial infarction or stroke, or death via reporting of events in the follow-up surveys via REDCap links or phone calls.
Time frame: At end of CR up to 2 years follow-up
Any full admission or observation status admission to a hospital with apparent life-threatening illness via reporting of events in the follow-up surveys via REDCap links or phone calls.
Time frame: At end of CR up to 2 years follow-up
A clinically indicated ischemic event during exercise stress test, nuclear stress test, exercise echo or cardiac catheterization via reporting of events in the follow-up surveys via REDCap links or phone calls.
Time frame: Start to end of CR
After enrollment to cardiac rehabilitation (CR) the number of sessions completed within 6 months, with a maximum of 36 possible via the case report forms completed per participant.
Contact information is provided by the study sponsor or research team.
Karen L Riska, PhD
CONTACT
Quinn R Pack, MD
CONTACT
Baystate Medical Center
Other
Improving Outcomes From Cardiac Rehabilitation Among Older Adults Through Exercise Testing and Individualized Exercise Intensity Prescriptions
Acronym: PACE SETTER
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05972070
Angina Pectoris, Angina, Stable
Brookfield, Connecticut, United States
View Trial DetailsNCT02722213
Angina Pectoris, Angina, Stable
Minneapolis, Minnesota, United States
View Trial DetailsNCT07252856
Cardiovascular Diseases, Heart Diseases
Leuven, Belgium
View Trial DetailsNCT06699056
Arrhythmias, Cardiac, Atrial Enlargement
Orange, California, United States
View Trial Details